Cargando…

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy

SIMPLE SUMMARY: Cancer immunotherapy has now attracted much attention because of the recent success of immune checkpoint inhibitors. However, they are only beneficial in a limited fraction of patients most probably due to lack of sufficient CD8+ cytotoxic T-lymphocytes against tumor antigens in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuo, Kazuhiko, Yoshie, Osamu, Kitahata, Kosuke, Kamei, Momo, Hara, Yuta, Nakayama, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161242/ https://www.ncbi.nlm.nih.gov/pubmed/34065346 http://dx.doi.org/10.3390/cancers13102495

Ejemplares similares

A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8(+) T Cells
por: Matsuo, Kazuhiko, et al.
Publicado: (2018)

Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity
por: Matsuo, Kazuhiko, et al.
Publicado: (2021)

EBV‐positive pyothorax‐associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3
por: Higuchi, Tomonori, et al.
Publicado: (2023)

Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
por: Qian, Chen, et al.
Publicado: (2020)

Research progress on dendritic cell vaccines in cancer immunotherapy
por: Yu, Jifeng, et al.
Publicado: (2022)

CCR4 as a Therapeutic Target for Cancer Immunotherapy
por: Yoshie, Osamu
Publicado: (2021)

Recent Progress in Immunotherapy for Gastric Cancer
por: Yoon, Jeesun, et al.
Publicado: (2023)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
por: Jähnisch, Hanka, et al.
Publicado: (2010)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021)

Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?
por: Butterfield, Lisa H.
Publicado: (2013)

Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
por: Aldahlawi, Alia M., et al.
Publicado: (2021)

Efficient Use of a Crude Drug/Herb Library Reveals Ephedra Herb As a Specific Antagonist for T(H)2-Specific Chemokine Receptors CCR3, CCR4, and CCR8
por: Matsuo, Kazuhiko, et al.
Publicado: (2016)

mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
por: Sasaki, Kosuke, et al.
Publicado: (2022)

Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy
por: Datta, Jashodeep, et al.
Publicado: (2014)

Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
por: Jeng, Long-Bin, et al.
Publicado: (2022)

Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)

Kidney GATA3(+) regulatory T cells play roles in the convalescence stage after antibody-mediated renal injury
por: Sakai, Ryota, et al.
Publicado: (2020)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)

Recent research and clinical progress of CTLA-4-based immunotherapy for breast cancer
por: Zhang, Hongsheng, et al.
Publicado: (2023)

Distinct features of dendritic cell-based immunotherapy as cancer vaccines
por: Lee, Chaelin, et al.
Publicado: (2018)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022)

The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
por: Kobayashi, Masanori, et al.
Publicado: (2014)

Dendritic Cell-Based Immunotherapy for Myeloid Leukemias
por: Schürch, Christian M., et al.
Publicado: (2013)

Dendritic Cell-Based Immunotherapy for Solid Tumors()()
por: Jung, Nam-Chul, et al.
Publicado: (2018)

Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
por: Hernández, Sabina Sánchez, et al.
Publicado: (2022)

Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
por: Nava, Sara, et al.
Publicado: (2021)

Dendritic Cell-Derived Exosomes in Cancer Immunotherapy
por: Luo, Shumin, et al.
Publicado: (2023)

Perspectives on Recent Progress in Focused Ultrasound Immunotherapy
por: Sheybani, Natasha D., et al.
Publicado: (2019)

The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
por: Bol, Kalijn F., et al.
Publicado: (2019)

Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
por: Ni, Ling
Publicado: (2022)

Dendritic Cells and Their Role in Immunotherapy
por: Gardner, Alycia, et al.
Publicado: (2020)

Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
por: Li, Yang, et al.
Publicado: (2021)

TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress
por: Shen, Xinyuan, et al.
Publicado: (2022)

Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
por: Yu, Yingyan, et al.
Publicado: (2023)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
por: Van Acker, Heleen H., et al.
Publicado: (2019)

Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors
por: Kang, Byeong Hoon, et al.
Publicado: (2022)

Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer
por: Cheng, Shanshan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rp55ngsji7b0utl0pqelj7ke1m